On September 21, 2026, BNP Paribas SA acquired 19.00 million shares of PHARMARON (03759) (H shares) by way of taking a security interest in shares, linked to convertible bond related derivative transactions. This was an off-exchange transaction and not a direct secondary-market dealing.
Prior to the acquisition, BNP Paribas SA's long position in PHARMARON was 15.67 million shares, representing 4.38%; following the acquisition, the holding changed to 19.00 million shares, with the long position ratio rising to 5.31%.